Back to search

Article

Effectiveness of slow-release oral morphine versus other OAT regimens in key sub-populations: protocol for population-based target trial emulation

2025-12-03

Abstract excerpt

<h4>Introduction</h4> Slow-release oral morphine (SROM) was introduced as an alternative form of opioid agonist treatment (OAT) in British Columbia (BC), Canada in 2017. While clinical guidelines in BC recommend SROM based on expert consensus and experience, there is limited real-world evidence on populations most likely to benefit from SROM compared to other forms of OAT, particularly in the context of widesprea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ec1312dd-e8a8-5125-aeb7-cbc29c7ead8d
DOI
10.64898/2025.11.30.25341316
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness of slow-release oral morphine versus other OAT regimens in key sub-populations: protocol for population-based target trial emulationDOI 10.64898/2025.11.30.25341316
What constitutes safe and effective dose titration of methadone and buprenorphine/naloxone? protocol for a population-based target trial emulationSemantic proximity
Factors associated with long-term opioid therapy discontinuation for people with chronic non-cancer pain in UK primary care: a population-based retrospective cohort studySemantic proximity
The effects of a provincial opioid prescribing standard on opioid prescribing for pain: interrupted series analysisSemantic proximity
Oxycodone/naloxone versus Tapentadol in real-world chronic non-cancer pain management: a prospective controlled and pharmacogenetic studySemantic proximity
Buprenorphine treatment of opioid dependence: analysis of individual patient dataSemantic proximity
Comparative effectiveness of preferred pharmacological treatment options for bipolar disorder among people with opioid use disorder in British Columbia and Ontario, Canada: protocol for parallel population-based target trial emulationsSemantic proximity
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: Protocol for an open-label, parallel-group, superiority, randomized controlled trialSemantic proximity
Regional anesthesia strategy does not influence postoperative opioid consumption after anterior total hip arthroplasty: a large retrospective cohort studySemantic proximity
Intravenous Buprenorphine Micro-Induction for Opioid Use Disorder in Patients Who Use Fentanyl: A Retrospective ReviewSemantic proximity
Cohort Profile: Baseline Characteristics of Veterans from Improving Veteran Access to Integrated Management of Back Pain (AIM-Back) – an Embedded Pragmatic, Cluster Randomized Trial in the United StatesSemantic proximity
Select a neighboring publication to make it the new centre.